News from optimer pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 01, 2013, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Reports Second Quarter 2013 Financial Results

 Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today unaudited financial results for the second quarter ended June 30, 2013....

Jul 25, 2013, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2013 Financial Results

 Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) (the "Company" or "Optimer") today announced it will report second quarter 2013 financial...

May 13, 2013, 16:04 ET

Optimer Pharmaceuticals Appoints Eric Sirota as Chief Operating Officer

 Optimer Pharmaceuticals (NASDAQ: OPTR) (the "Company" or "Optimer") today announced the appointment of Mr. Eric Sirota as Chief...

May 09, 2013, 16:02 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Reports First Quarter 2013 Financial Results

Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today unaudited financial results for the first quarter ended March 31, 2013....

May 02, 2013, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results

Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) (the "Company" or "Optimer") today announced it will report first quarter 2013 financial results...

Apr 26, 2013, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

DIFICID® (fidaxomicin) Tablets Approved in Australia

 Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Therapeutic Goods Administration, the Australian regulatory body for...

Mar 15, 2013, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that on March 14, 2013 the Compensation, Nominating, and Corporate Governance...

Feb 28, 2013, 16:06 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results

 Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today unaudited financial results for the fourth quarter and fiscal year...

Feb 27, 2013, 08:15 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that on February 26, 2013 the Inducement Award Sub-Committee of the Compensation,...

Feb 27, 2013, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals' Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer

 The Board of Directors of Optimer Pharmaceuticals (NASDAQ: OPTR) (the "Company" or "Optimer") today announced the appointment of its...

Feb 14, 2013, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

New Analysis Shows Age has a Significant Effect on Outcomes in Patients Being Treated for Clostridium difficile Infection (CDI)

 Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that the February 2013 Journal of the American Geriatrics Society published...

Feb 07, 2013, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year 2012 Financial Results

 Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced it will report fourth quarter and fiscal year 2012 financial results after the...

Feb 07, 2013, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals to Present at Leerink Swann Global Healthcare Conference

 Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Company will present at the Leerink Swann Global Healthcare Conference...

Feb 01, 2013, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

 Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that on January 31, 2013 the Inducement Award Sub-Committee of the Compensation,...

Jan 07, 2013, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals Reports Preliminary 2012 Gross Product Sales of $74.4 Million

Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today provided an update on 2012 sales for DIFICID (fidaxomicin) tablets, an antibacterial drug...

Dec 24, 2012, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that on December 21, 2012 the Inducement Grant Sub-committee of the Compensation,...

Dec 20, 2012, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference

Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Company will present at the 31st Annual J.P. Morgan Healthcare conference on...

Dec 05, 2012, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference

 Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Company will present at the 23rd Annual Oppenheimer Healthcare...

Dec 03, 2012, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals and AstraZeneca Collaborate to Commercialize Fidaxomicin for Clostridium Difficile Infection in Latin America

Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today the execution of an exclusive agreement with AstraZeneca to commercialize fidaxomicin...

Nov 07, 2012, 08:00 ET
Optimer Pharmaceuticals, Inc., logo. (PRNewsFoto/Optimer Pharmaceuticals, Inc.)

Optimer Pharmaceuticals to Present at November 2012 Investor Conferences

 Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Company will present at the below listed investor conferences in...